This announcement is a separate document:
北京市金杜律师事务所关于北京神州细胞生物技术集团股份公司2021年度向特定对象发行股票发行过程和认购对象合规性的法律意见书
Legal opinion of Beijing King & Co., Ltd. on the issuance process of shares issued to specific targets by Beijing Shenzhou Cell Biotechnology Group Co., Ltd. in 2021 and the compliance of subscribers
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.